Rep. Gilbert Ray Cisneros, Jr. Purchases Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Representative Gilbert Ray Cisneros, Jr. (D-California) recently bought shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on April 07th, the Representative disclosed that they had bought between $15,001 and $50,000 in UnitedHealth Group stock on March 31st. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of PTC (NASDAQ:PTC) on 4/1/2025.
• Sold $1,001 – $15,000 in shares of W. R. Berkley (NYSE:WRB) on 4/1/2025.
• Sold $15,001 – $50,000 in shares of GoDaddy (NYSE:GDDY) on 4/1/2025.
• Purchased $1,001 – $15,000 in shares of Ford Motor (NYSE:F) on 3/31/2025.
• Sold $15,001 – $50,000 in shares of Microsoft (NASDAQ:MSFT) on 3/31/2025.
• Sold $15,001 – $50,000 in shares of Pfizer (NYSE:PFE) on 3/31/2025.
• Purchased $1,001 – $15,000 in shares of Boeing (NYSE:BA) on 3/31/2025.
• Sold $1,001 – $15,000 in shares of Hologic (NASDAQ:HOLX) on 3/31/2025.
• Sold $15,001 – $50,000 in shares of Merck & Co., Inc. (NYSE:MRK) on 3/31/2025.
• Sold $1,001 – $15,000 in shares of Tesla (NASDAQ:TSLA) on 3/31/2025.

UnitedHealth Group Trading Up 1.1 %

Shares of NYSE:UNH traded up $6.20 on Wednesday, hitting $559.28. 2,764,496 shares of the company’s stock were exchanged, compared to its average volume of 4,292,627. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The business’s 50 day simple moving average is $509.40 and its two-hundred day simple moving average is $541.42. The stock has a market capitalization of $511.58 billion, a price-to-earnings ratio of 36.07, a price-to-earnings-growth ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. UnitedHealth Group’s revenue was up 6.8% compared to the same quarter last year. During the same period last year, the company posted $5.83 earnings per share. Analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.50%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 54.19%.

Hedge Funds Weigh In On UnitedHealth Group

Institutional investors and hedge funds have recently bought and sold shares of the business. Czech National Bank grew its position in shares of UnitedHealth Group by 5.9% in the first quarter. Czech National Bank now owns 211,375 shares of the healthcare conglomerate’s stock valued at $110,708,000 after purchasing an additional 11,839 shares in the last quarter. JGP Wealth Management LLC boosted its stake in UnitedHealth Group by 12.0% during the first quarter. JGP Wealth Management LLC now owns 1,020 shares of the healthcare conglomerate’s stock worth $534,000 after buying an additional 109 shares during the period. Mirador Capital Partners LP raised its position in UnitedHealth Group by 1.7% in the first quarter. Mirador Capital Partners LP now owns 11,161 shares of the healthcare conglomerate’s stock valued at $5,846,000 after purchasing an additional 183 shares during the period. Kaizen Financial Strategies boosted its position in shares of UnitedHealth Group by 30.3% during the first quarter. Kaizen Financial Strategies now owns 525 shares of the healthcare conglomerate’s stock worth $275,000 after buying an additional 122 shares during the period. Finally, Aletheian Wealth Advisors LLC lifted its position in shares of UnitedHealth Group by 9.4% during the first quarter. Aletheian Wealth Advisors LLC now owns 999 shares of the healthcare conglomerate’s stock worth $523,000 after purchasing an additional 86 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was bought at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.33% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. KeyCorp restated an “overweight” rating and set a $650.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Piper Sandler lowered their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Finally, Barclays reduced their price objective on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research note on Friday, January 17th. Twenty-one equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $630.35.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.

Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.